Brief: Aker Biomarine Acquires Patents, Equipment, And Scientific Data From Acasti Pharma
Oct 24 (Reuters) - Aker Biomarine ASA AKBM.OL :
* AKER BIOMARINE ACQUIRES PATENTS, EQUIPMENT, AND SCIENTIFIC
DATA
FROM ACASTI PHARMA INC
* DEAL IS SETTLEMENT TOWARDS CONTRACTUAL OBLIGATION OF $3.1
MILLION ACASTI HAS TOWARDS AKER BIOMARINE
* DEAL HAS NO CASH EFFECTS
Source text for Eikon: ID:nObidCt4na
Further company coverage: AKBM.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Aker Biomarine ASA
See all newsBrief: Aker Biomarine Secures Lysoveta Contract
Norway's Aker BioMarine Q1 revenue rises 13% on record krill oil sales
Brief: Aker Biomarine Q1 Adjusted EBITDA $12.5 Mln
Norway's Aker BioMarine exploring alternatives for Human Health Ingredient unit
Brief: Aker BioMarine Q4 Adjusted EBITDA USD 10.6 Million